Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Genocea Biosciences (GNCA)

Genocea Biosciences (GNCA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Genocea Biosciences 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 USA

P: 617-876-8191 F: 617-500-0969

Description:

Genocea Biosciences, Inc. is involved in developing vaccines. The company's proprietary discovery platform consists of AnTigen Lead Acquisition System which designs vaccines that stimulate T cell immunity. Its product portfolio which are in different clinical trials consist of GEN-003, HSV-2 infections, GEN-004 and HSV-2 prophylaxis and malaria. Genocea Biosciences, Inc. is headquartered in Cambridge, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 88,867
Shares Outstanding, K 24,549
Annual Sales, $ 0 K
Annual Net Income, $ -27,810 K
60-Month Beta 2.41
% of Insider Shareholders 2.33%
Float, K 23,977
% Float 97.67%

Growth:

1-Year Return -39.40%
3-Year Return -88.73%
5-Year Return -97.46%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 99.39%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 08/01/19
Earnings Per Share ttm -2.32
EPS Growth vs. Prev Qtr 18.18%
EPS Growth vs. Prev Year 35.71%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 1-8 on 05/22/19

GNCA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -1.71
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -468.08
Return-on-Assets (Before Tax) -93.56
Profit Margin % N/A
Net Margin % N/A
Debt/Equity 1.45
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 9.52
Book Value/Share 0.39
Interest Coverage -26.26
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar